Published in Pharmacotherapy on August 01, 2012
The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich) (2011) 1.60
Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control. Hypertension (2015) 1.48
Economics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic Review. Am J Prev Med (2015) 0.80
A centralized cardiovascular risk service to improve guideline adherence in private primary care offices. Contemp Clin Trials (2015) 0.78
A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence. Pharmacotherapy (2015) 0.78
Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients. J Am Pharm Assoc (2003) (2016) 0.75
Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones. J Am Heart Assoc (2016) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med (2009) 5.75
The lifetime risk of stroke: estimates from the Framingham Study. Stroke (2006) 4.68
Quality improvement strategies for hypertension management: a systematic review. Med Care (2006) 4.29
Results of the Medicare Health Support disease-management pilot program. N Engl J Med (2011) 4.10
The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med (2009) 4.10
A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) (2008) 2.37
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy (2003) 2.12
Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy (2010) 1.82
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy (2001) 1.19
Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens (Greenwich) (2011) 1.11
Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther (1997) 1.09
Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med (2009) 5.75
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension (2006) 3.89
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (2006) 3.02
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med (2010) 1.96
Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy (2010) 1.82
Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension (2004) 1.70
Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother (2004) 1.60
Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med (2005) 1.51
Combination therapy in hypertension. J Am Soc Hypertens (2010) 1.51
Effect of self-efficacy and social support on adherence to antihypertensive drugs. Pharmacotherapy (2010) 1.50
Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens (Greenwich) (2007) 1.31
Combination therapy in hypertension. J Am Soc Hypertens (2010) 1.28
A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes (2010) 1.26
Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci (2007) 1.25
Formation of a primary care pharmacist practice-based research network. Am J Health Syst Pharm (2007) 1.25
Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc (2003) (2004) 1.22
Evidence-based assessment of acute pain in older adults: current nursing practices and perceived barriers. Clin J Pain (2004) 1.20
Translating research into practice intervention improves management of acute pain in older hip fracture patients. Health Serv Res (2009) 1.13
Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens (Greenwich) (2011) 1.11
Physician adherence to blood pressure guidelines and its effect on seniors. Pharmacotherapy (2008) 1.10
Combination therapy in hypertension. J Clin Hypertens (Greenwich) (2010) 1.09
Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health (2005) 1.09
Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens (2010) 1.07
Utility of a questionnaire to measure physician-pharmacist collaborative relationships. J Am Pharm Assoc (2003) (2006) 1.07
A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research. Med Care (2010) 1.07
Estimation of Cachexia among Cancer Patients Based on Four Definitions. J Oncol (2009) 1.06
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States). Cancer Causes Control (2006) 1.06
Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm (2014) 1.03
Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med (2010) 1.03
Reduction in adverse symptoms as blood pressure becomes controlled. Pharmacotherapy (2008) 1.02
Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care. Pharmacotherapy (2013) 1.02
Acute pain treatment for older adults hospitalized with hip fracture: current nursing practices and perceived barriers. Appl Nurs Res (2003) 1.01
Patient and provider perceptions of hypertension treatment: do they agree? J Clin Hypertens (Greenwich) (2007) 0.97
Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication. Am J Epidemiol (2012) 0.96
The Iowa Continuity of Care study: Background and methods. Am J Health Syst Pharm (2008) 0.96
Development and reliability testing of the clinical pharmacist recommendation taxonomy. Pharmacotherapy (2007) 0.95
Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich) (2013) 0.95
Effect of evidence-based acute pain management practices on inpatient costs. Health Serv Res (2009) 0.93
Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice-based implementation trial. Pharmacotherapy (2013) 0.92
Outcomes following local therapy for early-stage breast cancer in non-trial populations. Breast Cancer Res Treat (2010) 0.92
Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich) (2013) 0.91
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile. Leuk Lymphoma (2014) 0.90
Physician-pharmacist collaborative management of asthma in primary care. Pharmacotherapy (2014) 0.90
Metastatic non-small cell lung cancer: costs associated with disease progression. Am J Manag Care (2008) 0.88
Summative index: Acute pain management in older adults. Appl Nurs Res (2009) 0.88
Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data. Am J Epidemiol (2011) 0.87
Development of a computer algorithm for defining an active drug list using an automated pharmacy database. J Clin Epidemiol (2003) 0.86
Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res (2014) 0.85
Using theory to predict implementation of a physician-pharmacist collaborative intervention within a practice-based research network. Res Social Adm Pharm (2013) 0.84
How well does a shortened time interval characterize results of a full ambulatory blood pressure monitoring session? J Clin Hypertens (Greenwich) (2008) 0.84
Population-based medication reviews: a descriptive analysis of the medication issues identified in a medicare not-for-profit prescription discount program. Ann Pharmacother (2004) 0.83
Underutilization of cardiovascular medications: effect of a continuity-of-care program. Am J Health Syst Pharm (2013) 0.81
All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich) (2009) 0.80
Equivalence of generic and brand-name drugs for cardiovascular disease. JAMA (2009) 0.79
Physician access and early nephrology care in elderly patients with end-stage renal disease. Kidney Int (2008) 0.79
Guidelines for use of diuretics: a view from a member of JNC 7. J Clin Hypertens (Greenwich) (2012) 0.78
Effect of hospitalization on inappropriate prescribing in elderly Medicare beneficiaries. J Am Geriatr Soc (2015) 0.78
Influence of patient characteristics on success of ambulatory blood pressure monitoring. Pharmacotherapy (2008) 0.78
Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involved. Pharmacotherapy (2010) 0.78
Pharmaceutical care services for patients with hypertension. Ann Pharmacother (2003) 0.78
Why physicians do not prescribe a thiazide diuretic. J Clin Hypertens (Greenwich) (2010) 0.77
Preventing thiazide-induced hyperglycemia: opportunities for clinical pharmacists. Pharmacotherapy (2008) 0.77
Challenges of Web-based education in educating nurses about evidence-based acute pain management practices for older adults. J Contin Educ Nurs (2004) 0.77
Effects of health savings account-eligible plans on utilization and expenditures. Am J Manag Care (2011) 0.77
A mixed-method approach to evaluate a pharmacist intervention for veterans with hypertension. J Clin Hypertens (Greenwich) (2014) 0.77
Estimating the effect of treatment rate changes when treatment benefits are heterogeneous: antibiotics and otitis media. Value Health (2008) 0.77
Evidence-based practice: an administrative perspective. Reflect Nurs Leadersh (2002) 0.77
Antihypertensive prescribing: do we have reason to celebrate? Hypertension (2006) 0.76
Estimating incremental costs with skew: a cautionary note. Appl Health Econ Health Policy (2012) 0.76
Development of diabetes with thiazide diuretics: the potassium issue. J Clin Hypertens (Greenwich) (2005) 0.76
The effect of physician characteristics and their practice environment on surgical referral patterns for early-stage breast cancer in Iowa. Am J Med Qual (2004) 0.76
Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts. Res Social Adm Pharm (2010) 0.76
Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study. BMC Nephrol (2012) 0.75
Measuring diabetes care in the national interdisciplinary primary care practice-based research network (NIPC-PBRN). Pharmacotherapy (2011) 0.75
Retail pharmacy market structure and insurer-independent pharmacy bargaining in the Medicare Part D era. Adv Health Econ Health Serv Res (2010) 0.75
Eplerenone--a novel selective aldosterone blocker. Ann Pharmacother (2002) 0.75
Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapy. Pharmacotherapy (2005) 0.75
Iowa medicare beneficiaries' satisfaction and experiences with a prescription drug discount card and preferred drug list. J Am Pharm Assoc (2003) (2006) 0.75
Extent of services provided by pharmacists in the iowa medicaid pharmaceutical case management program. J Am Pharm Assoc (2003) (2003) 0.75
Specifying a Conceptual Treatment Choice Relationship Before Analysis Is Necessary for Comparative Effectiveness Research. Med Care (2017) 0.75
Conditions for Generating Treatment Effect Estimates in Line With Objectives: Beyond Confounding. Med Care (2017) 0.75
Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens (2017) 0.75
Effect of a telephone medication renewal service on blood pressure control. J Am Pharm Assoc (2003) (2003) 0.75
Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens (2011) 0.75